300+ senior healthcare leaders navigating the rapidly evolving market and patient access landscape
By the Numbers
20+
sessions
70+
expert presentations
12
dedicated networking hours
1:1
curated meetings
WHY ACCESS FORUM? WHY NOW?
300+ senior healthcare leaders will descend on New Orleans to navigate the rapidly evolving market and patient access landscape in a completely reimagined Forum experience. You will explore how the new Administration in the US is driving unprecedented policy changes and global market dynamics creating worldwide ripple effects. Mastering both local and global strategy with cross-regional execution is now essential for success. The maelstrom demands expertise—and solutions. Patient access decisions made locally now reverberate globally, while evidence generation must resonate across continents and complex health structures.
SESSION TRACKS:
The U.S. market is experiencing significant shifts in policy, pricing, and distribution models that will define the future of access. This track invites proposals addressing topics such as:
The impact of U.S. healthcare policy changes, including IRA, IPAY, MFN, and executive orders
340B reform and its implications for stakeholders across the system
Evolving distribution models such as direct-to-consumer approaches
The role and challenges of PBMs in shaping access and pricing
Other U.S.-specific policy, payer, and market innovations affecting access strategies
Outside the U.S., market access landscapes are being redefined through regional collaborations, national policies, and country-specific innovations. This Track invites proposals exploring such topics as:
Pan-European initiatives such as EuHTANet and Joint Clinical Assessment (JCA)
Market-specific strategies and challenges in Europe, APAC, and Latin America
Policy frameworks that influence access and reimbursement outside the U.S.
Demonstrating and communicating value is central to market access. This track focuses on how real-world evidence and innovative methodologies can substantiate product value and strengthen payer and stakeholder engagement. Sessions may cover topics such as:
Success stories of RWE in supporting product adoption and reimbursement
Approaches for capturing and communicating RWE effectively in product value stories
Integrating evidence strategies across the lifecycle to drive access outcomes
Opportunities for global collaboration and alignment in value assessment and evidence generation
Digital transformation is reshaping every aspect of healthcare access, from how evidence is generated to how patients engage with care. This track focuses on the role of digital health, AI, and new technologies in accelerating access, creating efficiencies, and demonstrating value. Sessions may cover such topics such as:
Using AI to drive payer engagement and smarter decision-making
Digital tools and AI innovations that enhance patient experience and engagement
Case studies of innovative technologies immproving access and outcomes
Opportunities and challenges in capturing the value of digital solutions
ACCESS Forum US is more than just an event; it’s a curated experiencethat embraces quality over quantity.
INTEGRATED NETWORKING Forget the typical exhibit floor — we’ve reinvented the experience with vibrant lounges, leadership roundtables, and New Orleans–style cultural moments that spark real dialogue and guaranteed 1:1 connections. Attendance at ACCESS Forum US is intentionally limited to 400 leaders to ensure every conversation counts and every connection drives impact.
ATTENDANCE PATHWAYS
Invitation Only
Hosted Leaders
Traditional Registration
Limited Paid Passes
AGENDA
EVENT SCHEDULE
PRE-CONFERENCE
09:00–18:00
Executive Training Program: What you need to know to prepare for & oversee your Joint Clinical Assessment (JCA) Activities
19:00–21:00
Mardi Gras Nights! Second Line Parade & Offsite Reception
Join the rhythm of New Orleans as our very own ACCESS Forum marching band leads attendees from the Roosevelt down iconic Bourbon Street – accompanied by lively street performers – culminating in an unforgettable offsite cocktail reception featuring gourment food stations and live music that captures the true spirit of the city.
CONFERENCE DAY 1
08:00 – 09:00
Breakfast, 1:1 Meetings & Network Lounges
09:00 – 09:15
Welcome Remarks
09:15–10:00
Keynote Presentation
TBA by November 10
10:00 – 11:00
Plenary 1
TBA by November 10
11:00 – 11:45
Parallel Sessions: Choose 1 of 4 Interactive Panels and Workshops
TBA November 3
WS 1: WS 2: WS 3: WS 4:
13:00 – 14:30
Lunch, 1:1 Meetings & Networking Lounges
14:30 – 15:45
Parallel Sessions: Choose 1 of 4 Interactive Panels & Workshops
Step into the vibrant heart of the Forum as the Networking Hall transforms into a lively social experience – complete with curated live talent, immersive activations, and strolling entertainers. Enjoy cocktails and conversation wiht peers and solution partners in an atmosphere designed for meaningful connections and spontaneous moments of inspiration.
Conference Day 2
07:00 – 08:00
Breakfast, 1:1 Meetings & Networking Lounges
08:00 – 08:15
Welcome Remarks
08:15 – 09:15
Keynote Presentation 2
TBA by November 15
09:15 – 10:00
Morning Break, 1:1 Meetings & Newtorking Lounges
10:00 – 11:15
Parallel Sessions: Choose 1 of 4 Interactive Panels and Workshops
WS 9: WS 10: WS 11: WS 12:
11:15 – 12:15
Lunch, 1:1 Meetings & Networking Lounges
12:15 – 13:30
Parallel Sessions: Choose 1 of 4 Interactive Panels & Workshops
WS 13: WS 14: WS 15: WS 16:
13:30 – 14:15
Afternoon Break, 1:1 Meetings & Network Lounges3
14:15 – 15:15
Plenary 3
TBA by November 15
15:15 – 15:30
Conclusion & Adjournment
PLANNING COMMITTEE
Rob Glik
VP & GM, Global Market Access Consulting, IQVA
Chair, Planning Committee
Joseph Boswell
President, ACCESS Forum
Yash Jalundhwala
Senior Director, Global Market Access & Pricing, Moderna
Antti Kourula
VP, Head of Global Market Access, CSL Behring
Betsy Lahue
Founder & CEO Alkemi
Annette Powers
SVP, Head Global Value Access & Public Policy Astellas
Michael Scholler
Head of Global Access, Value and Policy — New Product Planning Astellas
Amir Tahami
Head, Global Value, Access & Evidence Eisai
Sean Tunis
Principal Rubik's Health
Gergana Zlateva
VP, Global Access Strategy & Pricing, Oncology Global Access & Value Pfizer